Subject: Dr. Leonard Lichtenfeld: Patient Access in CAR-T

Dr. Leonard Lichtenfeld: Patient Access in CAR-T

April 8th, 2019 at 11:46 am EDT

One of the biggest challenges facing the industry Ahead of the CAR-T Congress USA on April 16-17 in Boston, we are highlig ...

Are You Growing & Banking Back Your hMSCs?

March 25th, 2019 at 10:27 am EDT

Testing RoosterBio hMSCs in Your Application Just Got Easier. Gone are the days of banking ba ...

We manufactured a podcast!

March 22nd, 2019 at 10:19 am EDT

Panels aren't just for conferences Ahead of the CAR-T congress on April 16th - 17th in Boston, we are highlighting the key ...

Who are the top 10 Biotechs leading the way in CAR-T?

February 28th, 2019 at 11:01 am EDT

Our opinion on pioneers in the CAR-T space right now. READ THE ARTICLE The fourth annual CAR-T Congress USA ...

Say goodbye

January 16th, 2019 at 3:12 pm EDT

If you've been procrastinating about claiming the Global Regenerative Medicine (RM) Industry Database 2019, there's only a few hours left to get it at 50% off.Because I want you to have all the information you need to make an ...

Tmunity reveal all at the CAR-T Congress

January 15th, 2019 at 10:00 am EDT

Join the 4th annual CAR-T Congress in Boston, April 16- 17 to discover how to overcome the key challenges to CAR-T cell therapy. Final agenda released for CAR-T Congress USA ...

Regenerative medicine companies surge in 2019

January 12th, 2019 at 6:30 am EDT

It's official. Regenerative medicine (RM) companies are surging in 2019. As featured in th ...

Final hours...

December 31st, 2018 at 2:49 pm EDT

This is the LAST reminder about BioInformant's New Year’s deal. If you’ve been thinking ...

Happy holidays! 20% off sitewide

December 21st, 2018 at 1:55 pm EDT

Dear colleague, With the holidays upon us, BioInformant is running its biggest sale of the y ...

Agenda preview enclosed for CAR-T Congress USA

December 13th, 2018 at 9:56 am EDT

Join the 4th annual CAR-T Congress in Boston, April 16- 17 to discover how to overcome the key challenges to Dear colleague, As 2018 draws to a close and long awaited large scale clinical trial data surfaces, ...